• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然淋巴细胞在代谢性和酒精相关性肝病中的作用。

Roles of innate lymphoid cells in metabolic and alcohol-associated liver diseases.

作者信息

Bourinet Manon, Anty Rodolphe, Gual Philippe, Luci Carmelo

机构信息

Université Côte d'Azur, INSERM, U1065, C3M, Nice, France.

Université Côte d'Azur, CHU, INSERM, U1065, C3M, Nice, France.

出版信息

JHEP Rep. 2023 Nov 11;6(2):100962. doi: 10.1016/j.jhepr.2023.100962. eCollection 2024 Feb.

DOI:10.1016/j.jhepr.2023.100962
PMID:38304237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10831956/
Abstract

Innate lymphoid cells (ILCs) have been identified as potent regulators of inflammation, cell death and wound healing, which are the main biological processes involved in the progression of chronic liver disease. Obesity and chronic alcohol consumption are the leading contributors to chronic liver diseases in developed countries, due to inappropriate lifestyles. In particular, inflammation is a key factor in these liver abnormalities and promotes the development of more severe lesions such as fibrosis, cirrhosis and hepatocellular carcinoma. Opposite roles of ILC subsets have been described in the development of chronic liver disease, depending on the stage and aetiology of the disease. The heterogeneous family of ILCs encompasses cytotoxic natural killer cells, the cytokine-producing type 1, 2 and 3 ILCs and lymphoid tissue inducer cells. Dysfunction of these immune cells provokes uncontrolled inflammation and tissue damage, which are the basis for tumour development. In this review, we provide an overview of the recent and putative roles of ILC subsets in obesity and alcohol-associated liver diseases, which are currently the major contributors to end-stage liver complications such as fibrosis/cirrhosis and hepatocellular carcinoma.

摘要

固有淋巴细胞(ILC)已被确认为炎症、细胞死亡和伤口愈合的有效调节因子,而这些是慢性肝病进展过程中的主要生物学过程。在发达国家,由于生活方式不当,肥胖和长期大量饮酒是慢性肝病的主要成因。特别是,炎症是这些肝脏异常的关键因素,并促进更严重病变如纤维化、肝硬化和肝细胞癌的发展。根据疾病的阶段和病因,ILC亚群在慢性肝病的发展中发挥着相反的作用。ILC的异质性家族包括细胞毒性自然杀伤细胞、产生细胞因子的1型、2型和3型ILC以及淋巴组织诱导细胞。这些免疫细胞的功能障碍会引发不受控制的炎症和组织损伤,而这是肿瘤发展的基础。在本综述中,我们概述了ILC亚群在肥胖和酒精相关性肝病中的最新作用及推测作用,目前这些疾病是导致纤维化/肝硬化和肝细胞癌等终末期肝脏并发症的主要原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39c7/10831956/fbb2daefe561/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39c7/10831956/c6fbdb07316a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39c7/10831956/fbb2daefe561/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39c7/10831956/c6fbdb07316a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39c7/10831956/fbb2daefe561/gr2.jpg

相似文献

1
Roles of innate lymphoid cells in metabolic and alcohol-associated liver diseases.天然淋巴细胞在代谢性和酒精相关性肝病中的作用。
JHEP Rep. 2023 Nov 11;6(2):100962. doi: 10.1016/j.jhepr.2023.100962. eCollection 2024 Feb.
2
Natural Killer Cells and Type 1 Innate Lymphoid Cells Are New Actors in Non-alcoholic Fatty Liver Disease.自然杀伤细胞和 1 型先天淋巴细胞是非酒精性脂肪性肝病的新角色。
Front Immunol. 2019 May 28;10:1192. doi: 10.3389/fimmu.2019.01192. eCollection 2019.
3
Development of Human ILCs and Impact of Unconventional Cytotoxic Subsets in the Pathophysiology of Inflammatory Diseases and Cancer.人类固有淋巴细胞的发育及其在炎症性疾病和癌症病理生理学中的非常规细胞毒性亚群的影响。
Front Immunol. 2022 May 26;13:914266. doi: 10.3389/fimmu.2022.914266. eCollection 2022.
4
The Role of Innate Lymphoid Cells in Immune-Mediated Liver Diseases.天然淋巴细胞在免疫介导性肝病中的作用。
Front Immunol. 2017 Jun 13;8:695. doi: 10.3389/fimmu.2017.00695. eCollection 2017.
5
The Metabolic Basis of ILC Plasticity.ILC 可塑性的代谢基础。
Front Immunol. 2022 Apr 29;13:858051. doi: 10.3389/fimmu.2022.858051. eCollection 2022.
6
The Influence of Innate Lymphoid Cells and Unconventional T Cells in Chronic Inflammatory Lung Disease.固有淋巴细胞和非常规 T 细胞在慢性炎症性肺病中的影响。
Front Immunol. 2019 Jul 11;10:1597. doi: 10.3389/fimmu.2019.01597. eCollection 2019.
7
Single-cell RNA-seq identifies a PD-1 ILC progenitor and defines its development pathway.单细胞 RNA 测序鉴定出 PD-1 ILC 祖细胞及其发育途径。
Nature. 2016 Nov 3;539(7627):102-106. doi: 10.1038/nature20105. Epub 2016 Sep 29.
8
Signaling Pathways Tuning Innate Lymphoid Cell Response to Hepatocellular Carcinoma.信号通路调控固有淋巴细胞对肝细胞癌的反应。
Front Immunol. 2022 Feb 23;13:846923. doi: 10.3389/fimmu.2022.846923. eCollection 2022.
9
Innate Lymphoid Cells (ILCs) as Mediators of Inflammation, Release of Cytokines and Lytic Molecules.先天淋巴细胞(ILCs)作为炎症、细胞因子和裂解分子释放的介质。
Toxins (Basel). 2017 Dec 10;9(12):398. doi: 10.3390/toxins9120398.
10
Human innate lymphoid cells.人类先天淋巴细胞。
Blood. 2014 Jul 31;124(5):700-9. doi: 10.1182/blood-2013-11-427781. Epub 2014 Apr 28.

引用本文的文献

1
From "Traditional" to "Trained" Immunity: Exploring the Novel Frontiers of Immunopathogenesis in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).从“传统”免疫到“训练有素”的免疫:探索代谢功能障碍相关脂肪性肝病(MASLD)进展中免疫发病机制的新前沿
Biomedicines. 2025 Aug 18;13(8):2004. doi: 10.3390/biomedicines13082004.
2
CD44 in Group 1 Innate Lymphoid Cells Impacts the Development and Progression of Steatohepatitis.第1组固有淋巴细胞中的CD44影响脂肪性肝炎的发生发展。
Liver Int. 2025 Sep;45(9):e70299. doi: 10.1111/liv.70299.
3
Inflammation in MASLD progression and cancer.

本文引用的文献

1
An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH.NASH 的抗炎和抗纤维化治疗靶点的综合观点。
J Hepatol. 2023 Aug;79(2):552-566. doi: 10.1016/j.jhep.2023.03.038. Epub 2023 Apr 14.
2
Identification and characterization of a hepatic IL-13-producing ILC3-like population potentially involved in liver fibrosis.鉴定和表征一种潜在参与肝纤维化的肝内产生 IL-13 的 ILC3 样细胞群。
Hepatology. 2023 Sep 1;78(3):787-802. doi: 10.1097/HEP.0000000000000350. Epub 2023 Apr 10.
3
Combination immunotherapy for hepatocellular carcinoma.
非酒精性脂肪性肝病进展与癌症中的炎症
JHEP Rep. 2025 Apr 2;7(8):101414. doi: 10.1016/j.jhepr.2025.101414. eCollection 2025 Aug.
4
Incretins and MASLD: at the Crossroads of Endocrine and Hepatic Disorders.肠促胰岛素与代谢相关脂肪性肝病:内分泌与肝脏疾病的交汇点
Curr Obes Rep. 2025 Jun 25;14(1):56. doi: 10.1007/s13679-025-00646-8.
5
The multifaceted roles of B lymphocytes in metabolic dysfunction-associated steatotic liver disease.B 淋巴细胞在代谢相关脂肪性肝病中的多效性作用。
Front Immunol. 2024 Sep 20;15:1447391. doi: 10.3389/fimmu.2024.1447391. eCollection 2024.
6
Role of the type 3 cytokines IL-17 and IL-22 in modulating metabolic dysfunction-associated steatotic liver disease.细胞因子 IL-17 和 IL-22 在调节代谢相关脂肪性肝病中的作用。
Front Immunol. 2024 Aug 2;15:1437046. doi: 10.3389/fimmu.2024.1437046. eCollection 2024.
肝细胞癌的联合免疫治疗。
J Hepatol. 2023 Aug;79(2):506-515. doi: 10.1016/j.jhep.2023.03.003. Epub 2023 Mar 16.
4
Innate Lymphoid Cell Plasticity in Mucosal Infections.黏膜感染中固有淋巴细胞的可塑性
Microorganisms. 2023 Feb 12;11(2):461. doi: 10.3390/microorganisms11020461.
5
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease.美国肝病研究学会非酒精性脂肪性肝病临床评估与管理实践指南
Hepatology. 2023 May 1;77(5):1797-1835. doi: 10.1097/HEP.0000000000000323. Epub 2023 Mar 17.
6
Single-cell RNA sequencing identifies a population of human liver-type ILC1s.单细胞 RNA 测序鉴定出一群人肝 ILC1 细胞。
Cell Rep. 2023 Jan 31;42(1):111937. doi: 10.1016/j.celrep.2022.111937. Epub 2023 Jan 1.
7
NR4A1 mediates NK-cell dysfunction in hepatocellular carcinoma via the IFN-γ/p-STAT1/IRF1 pathway.NR4A1 通过 IFN-γ/p-STAT1/IRF1 通路介导肝癌中 NK 细胞功能障碍。
Immunology. 2023 May;169(1):69-82. doi: 10.1111/imm.13611. Epub 2022 Dec 1.
8
To kill or not to kill - The role of the tumor microenvironment in shaping group 1 ILC functions.杀还是不杀 - 肿瘤微环境在塑造 ILC1 功能组中的作用。
Semin Immunol. 2022 Nov;61-64:101670. doi: 10.1016/j.smim.2022.101670. Epub 2022 Nov 10.
9
Interplay Between Liver Type 1 Innate Lymphoid Cells and NK Cells Drives the Development of Alcoholic Steatohepatitis.肝 1 型固有淋巴细胞与 NK 细胞之间的相互作用促进酒精性肝炎的发生。
Cell Mol Gastroenterol Hepatol. 2023;15(1):261-274. doi: 10.1016/j.jcmgh.2022.09.010. Epub 2022 Sep 27.
10
Bringing natural killer cells to the clinic.将自然杀伤细胞推向临床。
J Exp Med. 2022 Oct 3;219(10). doi: 10.1084/jem.20220830. Epub 2022 Sep 6.